Losses widen at Shorla Oncology
Chief executive Sharon Cunningham was commenting on new accounts for the Clonmel headquartered Shorla Pharma Ltd which show that the group recorded a pre-tax lopretax8.07m in 2023 as the business continued in its development phase.
The pretax loss followed a €6.2 million loss in 2022.
Last year, Sharon Cunningham and Orlaith Ryan from Shorla Oncology were named 2024 EY Entrepreneurs Of The Year.
READ MORE
Ms Cunningham said: 'Our business is very capital intensive in the product development phase. It takes several years to develop and commercialise pharmaceutical drugs to start generating revenue and realise a return''
The company is currently conducting another round of fundraising after having already raised $45 million, she added.
The accounts show that the company recorded its first revenues in 2023 at €2.49 million and Ms Cunningham said: 'There was a significant increase in revenues in 2024 and we expect another significant increase in revenues this year.'
Research and development spending increased from €2.12 million to €3.26 million in 2023.
'We are very pleased with the progress of our business and we are exactly where we planned to be and want to be from a revenue and pipeline progression perspective,' Ms Cunningham said.
The company has currently four FDA approved medicines for the US market and launched the fourth of those this week in the US.
It also has a US office at Cambridge, Massachusetts where Ms Cunningham is based.
The Waterford native said that numbers employed now total 45 and said that she expects employee numbers to increase further this year.
The accounts show a capital injection of €28.45 million in 2023 resulted in the company having shareholder funds of €17.12 million at the end of 2023.
Asked on the impact of winning the EY Entrepreneur of the Year for 2024, Ms Cunningham said that it has been ' phenomen'l'.
'It's extremely beneficial to have access to such a dynamic group of successful entrepreneurs and winning the competition overall has provided validation and further credibility of our business''
The company will be representing Ireland in the world EY Entrepreneur of the year competition in Monaco in June.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Irish Independent
6 days ago
- Irish Independent
Radio ad revenue up 2pc this year
This was 2pc up on the same period last year, and driven by a strong performance by digital audio, which was up 4.1pc to €3.6m. This does not include income from global audio platforms such as Acast and Spotify. The calculations were done by Radiocentre Ireland based on information supplied by RTE and all 34 independent radio stations. The €79.4m earned between January and June included €61.3m in 'spot revenue', from radio commercials. This was up 3pc year on year. Branded content revenue – including sponsorships and partnerships – totalled €14.5m, and was down almost 3pc. The second quarter – April to June – was particularly strong, with revenues up 3.4pc. Industry sources say, however, that July and August are proving more challenging, and likely to show a decline from 2024 when the equivalent months featured the Olympics in France and the European Championships in Germany. 'The main drivers of sector revenue in the first half of 2025 were retail, utilities, motor and finance,' said Ciarán Cunningham, the chief executive of Radiocentre Ireland. 'There was also strong growth in the IT, gardening and agriculture, and pharmaceutical sectors.' He said that while full figures for total advertising are not available yet, the initial indications are that the radio sector is outperforming the broader media market. 'Despite challenging economic conditions, it is great to see continued growth in radio revenue, with advertisers large and small recognising its power and leveraging its incredible strengths: highly cost-effective, unmatched reach, trust-building capacity, and creative effectiveness,' Mr Cunningham added. 'Radio content continues to attract very strong audiences, with people tuning in whenever they want and wherever they are, through a range of devices including smart speakers, mobile phones, and FM at home or in the car.' Media analysts generally are reporting that the month of June was one of recovery, following a steep decline in consumer sentiment in April and May, which was fuelled by the uncertainty caused by US President Donald Trump's announcement of swingeing tariffs on imports to America. 'Concerns over the cost-of-living have eased slightly, returning to levels seen prior to April 2025 when worries about Trump's tariffs first emerged,' according to a report on consumer sentiment in June by Core. 'However, half of the population still expresses concern over the cost-of-living in Ireland.'
Irish Times
25-07-2025
- Irish Times
Some could lose out in means-tested child benefit
The introduction of a second tier, means-tested child benefit payment would involve the replacement of some existing supports and could lead to some lower-income households losing out financially, the Tax Strategy Group (TSG) papers suggest. Marin Wall reports. Staying with the TSG papers, Cliff Taylor tells us that the income tax dilemma faced by the Government in framing October's budget is underlined in the key pre-budget papers, which say that indexing tax bands and credits for inflation would cost over €1 billion. And on the same subject Barry O'Halloran says that boosting betting tax in the budget would raise up to an extra €53 million a year for the State, according to Department of Finance officials, while Michael McAleer informs us that a 1 per cent increase in the higher rates of Vehicle Registration Tax (VRT) is one of the budget options outlined by the TSG papers. The European Union is pushing for any future tariffs on pharmaceutical products sold to the United States to be capped at a blanket 15 per cent rate, in ongoing trade negotiations with US President Donald Trump's administration. READ MORE Pharmaceutical products have emerged as one potential sticking point in intense EU-US negotiations to land a tariff agreement in the next eight days. Jack Power reports from Luxembourg. An Coimisiún Pleanála has given the green light for plans to demolish a Smyth's pub on Haddington Road and replace it with a bar and apartments despite locals' fears of a 'superpub' being developed. Gordon Deegan reports. How will the updated National Development Plan shape Ireland in years to come? Listen | 35:59 October's budget is quickly coming into focus, with the Government publishing a key pre-budget document, the Summer Economic Statement, this week. And Ministers face a string of key decisions about the shape of the package, which will have implications for voters' pockets. Voters have got used to giveaway budgets. But despite budget measures of €9.4 billion being signalled, the benefits to households could be significantly less. Here are the big calls facing the Cabinet from Cliff Taylor. In terms of pay, 2024 was a bumper year for the 21 long-standing bosses of the largest Irish publicly-quoted companies, driven by large bonuses paid by companies that exited the Dublin market and moved their primary listings to New York, writes Joe Brennan in Agenda. Figures compiled by The Irish Times show that their average pay package rose by 31 per cent to €4.36 million last year. The median chief executive compensation package, which gives a better picture of the pay landscape as it eliminates the distorting effects of outliers on the pay scales, rose by 16 per cent to €2.53 million. That's 56 times the median salary in Ireland, of about €45,000. We profile four of the eight finalists in the emerging category for this year's EY Entrepreneur of the Year awards. The finalists will vie to become EY Entrepreneur of the Year at a ceremony later this year. The four are: Alan Doyle of Aerlytix; Eddie Dillon of CreditLogic; Aidan O'Shea and Hilary O'Shea of Otonomee and Caitriona Ryan and Niki Ralph of The Institute of Dermatologists In our Friday column Brooke Masters looks at the issue of Donald Trump, Coca-Cola and cane sugar. Last Wednesday, the US president posted on Truth Social that Coca-Cola had agreed to change the domestic formula of its namesake drink to feature 'REAL Cane Sugar' rather than high-fructose corn syrup. The company patently was not ready. But six days later it finally confirmed it would launch a US cane sugar cola in the autumn. If you'd like to read more about the issues that affect your finances try signing up to On the Money , the weekly newsletter from our personal finance team, which will be issued every Friday to Irish Times subscribers.
RTÉ News
17-06-2025
- RTÉ News
Neurent Medical to create 125 jobs in Galway
Healthcare company Neurent Medical is to create 125 new highly skilled jobs in Galway over the next three years. The announcement comes as the company officially opened its new state-of-the-art manufacturing facility at Westlink Commercial Park in Oranmore. The new facility will serve as the central hub for the production of the company's Neuromark system, a treatment option designed to target the underlying drivers of chronic Rhinitis. The new Galway jobs will range across key functions in engineering, quality control, operations, supply chain management, and sales and marketing. Originating from the Enterprise Ireland-supported BioInnovate Ireland Programme, Neurent Medical has grown from concept to commercialisation within a decade, emerging as one of the country's MedTech success stories. Since its inception, it said it has leveraged Galway's world-class innovation ecosystem to scale its team, secure FDA regulatory clearances and attract top international clinical collaborators. Brian Shields, CEO of Neurent Medical, said the company was proud to scale its operations in Galway, where the MedTech ecosystem continues to thrive. "Our new Westlink facility gives us the manufacturing capacity to meet growing demand for Neuromark, while creating high skilled employment opportunities and contributing to economic vitality in the west of Ireland," he said. "As an Irish-founded company, we're excited to manufacture our product locally with the exceptional skills available and deliver Irish-engineered MedTech innovation to the world," he added. Jenny Melia, Executive Director and incoming CEO at Enterprise Ireland, said today's announcement of new jobs based here in Oranmore shows that Ireland is leading in research and development within the medical device space. "Neurent Medical has experienced impressive growth in a short period of time beginning its journey through the BioInnovate Ireland Programme here in Galway with further support awarded through EI's Commercialisation fund programme and through the Disruptive Technologies Innovation Fund administered by Enterprise Ireland for the development of the Neuromark technology," she said. "Supporting Irish companies with the ambition to scale globally is a key priority for Enterprise Ireland and we will continue to work closely with Brian and the team at Neurent Medical to optimise their full international growth potential, creating and sustaining jobs here in the Galway region," she added. Hildegarde Naughton, Minister of State at the Department of Children, Disability and Equality, noted that Galway is home to eight of the world's top 10 MedTech companies. "It is also highly notable that this is an Irish company, supported by Enterprise Ireland, and selling into the US market. I have no doubt, given their impressive growth to date, that this will be but one of many major achievements for the company," she added.
